Concurrent Overexpression of MYC and BCL2 by Dual Immunohistochemistry Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details